These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 343651)

  • 1. Pathophysiology of capillary circulation: Raynaud's disease.
    Arnot RS; Boroda C; Peacock JH
    Angiology; 1978 Jan; 29(1):48-52. PubMed ID: 343651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.
    Antcliff AC; Bouhoutsos J; Martin P; Morris T
    Angiology; 1974 May; 25(5):312-6. PubMed ID: 4823806
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of digital artery adrenoceptors in Raynaud's disease.
    Cooke JP; Creager SJ; Scales KM; Ren C; Tsapatsaris NP; Beetham WP; Creager MA
    Vasc Med; 1997; 2(1):1-7. PubMed ID: 9546943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total and capillary fingertip blood flow in Raynaud's phenomenon.
    Coffman JD; Cohen AS
    N Engl J Med; 1971 Jul; 285(5):259-63. PubMed ID: 5090397
    [No Abstract]   [Full Text] [Related]  

  • 5. Exaggerated postural vasoconstrictor reflex in Raynaud's phenomenon.
    Olsen N; Petring OU; Rossing N
    Br Med J (Clin Res Ed); 1987 May; 294(6581):1186-8. PubMed ID: 3109573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute effects of nifedipine on digital blood flow in human subjects with Raynaud's phenomenon: a double blind placebo controlled trial.
    Wise RA; Malamet R; Wigley FM
    J Rheumatol; 1987 Apr; 14(2):278-83. PubMed ID: 3298649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.
    Sunderland GT; Belch JJ; Sturrock RD; Forbes CD; McKay AJ
    Clin Rheumatol; 1988 Mar; 7(1):46-9. PubMed ID: 3044673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of topical minoxidil on digital blood flow in patients with Raynaud's phenomenon.
    Whitmore SE; Wigley FM; Wise RA
    J Rheumatol; 1995 Jan; 22(1):50-4. PubMed ID: 7699682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reserpine and Raynaud's phenomenon.
    Gifford RW
    N Engl J Med; 1971 Jul; 285(5):290-1. PubMed ID: 5090401
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.
    Lukác J; Rovenský J; Tauchmannová H; Zitnan D
    Drugs Exp Clin Res; 1985; 11(9):659-63. PubMed ID: 3916837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of misoprostol on digital circulation in patients with Raynaud's phenomenon.
    Wise RA; Wigley F
    J Rheumatol; 1994 Jan; 21(1):80-3. PubMed ID: 8151594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raynaud's disease and cooling of the fingers.
    Miller IA; Walder DN
    Br J Surg; 1972 Apr; 59(4):312. PubMed ID: 5020774
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.
    Arneklo-Nobin B; Elmér O; Akesson A
    Int Angiol; 1988; 7(1):19-25. PubMed ID: 3290356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy.
    Fries R; Shariat K; von Wilmowsky H; Böhm M
    Circulation; 2005 Nov; 112(19):2980-5. PubMed ID: 16275885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of Raynaud's disease.
    Halperin JL; Coffman JD
    Arch Intern Med; 1979 Jan; 139(1):89-92. PubMed ID: 760690
    [No Abstract]   [Full Text] [Related]  

  • 16. An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud's phenomenon.
    Holti G
    J Int Med Res; 1979; 7(6):473-83. PubMed ID: 391622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Objective relief of vasospasm by glyceryl trinitrate in secondary Raynaud's phenomenon.
    Coppock JS; Hardman JM; Bacon PA; Woods KL; Kendall MJ
    Postgrad Med J; 1986 Jan; 62(723):15-8. PubMed ID: 3099273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of isosorbide mononitrate on skin blood flow in patients with Raynaud's syndrome].
    Gross R; Galus K; Zajac S; Jedrasik M
    Wiad Lek; 2002; 55(1-2):29-34. PubMed ID: 12043312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital pressure and flow measurement upon local cooling in Raynaud's disease. Effect of naftidrofuryl.
    Bounameaux HM; Hellemans H; Verhaege R
    Int Angiol; 1986; 5(1):39-44. PubMed ID: 3734514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the plethysmographic amplification factor during vasodilator treatment. Healthy subject versus primary Raynaud phenomenon].
    Lasfargues G; Royere D; Perrotin D; Titon JP; Soutif D; Guilmot JL
    J Mal Vasc; 1987; 12(4):319-22. PubMed ID: 3694055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.